

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.64420659 |
| 2 | negative regulation of cell killing (GO:0031342) | 5.64420659 |
| 3 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.30069249 |
| 4 | positive regulation by symbiont of host defense response (GO:0052509) | 5.27273468 |
| 5 | modulation by symbiont of host defense response (GO:0052031) | 5.27273468 |
| 6 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.27273468 |
| 7 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.27273468 |
| 8 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.27273468 |
| 9 | modulation by symbiont of host immune response (GO:0052553) | 5.27273468 |
| 10 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.11871280 |
| 11 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.08847022 |
| 12 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.03988673 |
| 13 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.77184825 |
| 14 | macrophage activation involved in immune response (GO:0002281) | 4.56478901 |
| 15 | neutrophil activation involved in immune response (GO:0002283) | 4.47689899 |
| 16 | detection of other organism (GO:0098543) | 4.43070412 |
| 17 | negative regulation of histone methylation (GO:0031061) | 4.40953719 |
| 18 | DNA unwinding involved in DNA replication (GO:0006268) | 4.40363245 |
| 19 | * viral transcription (GO:0019083) | 4.34144031 |
| 20 | detection of bacterium (GO:0016045) | 4.30029557 |
| 21 | negative regulation of interleukin-12 production (GO:0032695) | 4.28400232 |
| 22 | protein-DNA complex disassembly (GO:0032986) | 4.26078713 |
| 23 | nucleosome disassembly (GO:0006337) | 4.26078713 |
| 24 | histone H2A acetylation (GO:0043968) | 4.25347186 |
| 25 | peptidyl-arginine omega-N-methylation (GO:0035247) | 4.23297916 |
| 26 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.23127045 |
| 27 | response to peptidoglycan (GO:0032494) | 4.20175503 |
| 28 | translational termination (GO:0006415) | 4.14874744 |
| 29 | maturation of SSU-rRNA (GO:0030490) | 4.12404621 |
| 30 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 4.05820159 |
| 31 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 4.05820159 |
| 32 | ribosomal small subunit assembly (GO:0000028) | 4.02638960 |
| 33 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.02042192 |
| 34 | immunoglobulin mediated immune response (GO:0016064) | 4.02006458 |
| 35 | ribosomal small subunit biogenesis (GO:0042274) | 4.01410144 |
| 36 | formation of translation preinitiation complex (GO:0001731) | 3.91209104 |
| 37 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.90101500 |
| 38 | translational elongation (GO:0006414) | 3.86887619 |
| 39 | regulation of gene silencing by RNA (GO:0060966) | 3.82007549 |
| 40 | regulation of posttranscriptional gene silencing (GO:0060147) | 3.82007549 |
| 41 | regulation of gene silencing by miRNA (GO:0060964) | 3.82007549 |
| 42 | DNA damage response, detection of DNA damage (GO:0042769) | 3.79708917 |
| 43 | regulation of histone H3-K9 methylation (GO:0051570) | 3.78539615 |
| 44 | translational initiation (GO:0006413) | 3.77839058 |
| 45 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.75075992 |
| 46 | regulation of gamma-delta T cell activation (GO:0046643) | 3.74086379 |
| 47 | peptidyl-arginine N-methylation (GO:0035246) | 3.71911485 |
| 48 | peptidyl-arginine methylation (GO:0018216) | 3.71911485 |
| 49 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.70385793 |
| 50 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.70385793 |
| 51 | detection of external biotic stimulus (GO:0098581) | 3.68830635 |
| 52 | germinal center formation (GO:0002467) | 3.63400195 |
| 53 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 3.62869181 |
| 54 | histone arginine methylation (GO:0034969) | 3.61479700 |
| 55 | positive regulation of mast cell activation (GO:0033005) | 3.60912311 |
| 56 | regulation of mast cell degranulation (GO:0043304) | 3.58857550 |
| 57 | negative regulation of RNA splicing (GO:0033119) | 3.56178356 |
| 58 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 3.55912877 |
| 59 | protein complex disassembly (GO:0043241) | 3.55647064 |
| 60 | response to muramyl dipeptide (GO:0032495) | 3.54871084 |
| 61 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.54049138 |
| 62 | response to host immune response (GO:0052572) | 3.54049138 |
| 63 | cellular extravasation (GO:0045123) | 3.53604524 |
| 64 | NIK/NF-kappaB signaling (GO:0038061) | 3.48635088 |
| 65 | ribosome biogenesis (GO:0042254) | 3.46013700 |
| 66 | detection of biotic stimulus (GO:0009595) | 3.45197975 |
| 67 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.43493767 |
| 68 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.42932009 |
| 69 | cellular protein complex disassembly (GO:0043624) | 3.40271529 |
| 70 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.39160913 |
| 71 | leukocyte aggregation (GO:0070486) | 3.38749418 |
| 72 | detection of molecule of bacterial origin (GO:0032490) | 3.37935983 |
| 73 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.37381724 |
| 74 | protein localization to kinetochore (GO:0034501) | 3.36588788 |
| 75 | regulation of chromatin binding (GO:0035561) | 3.36235502 |
| 76 | viral life cycle (GO:0019058) | 3.35529777 |
| 77 | spliceosomal snRNP assembly (GO:0000387) | 3.35488561 |
| 78 | regulation of leukocyte degranulation (GO:0043300) | 3.35187569 |
| 79 | RNA splicing, via transesterification reactions (GO:0000375) | 3.34737096 |
| 80 | mRNA splicing, via spliceosome (GO:0000398) | 3.34356950 |
| 81 | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377) | 3.34356950 |
| 82 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.33893572 |
| 83 | microglial cell activation (GO:0001774) | 3.33875907 |
| 84 | macromolecular complex disassembly (GO:0032984) | 3.33734812 |
| 85 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.33327353 |
| 86 | response to type I interferon (GO:0034340) | 3.32752194 |
| 87 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.32375033 |
| 88 | DNA replication-dependent nucleosome organization (GO:0034723) | 3.31580404 |
| 89 | DNA replication-dependent nucleosome assembly (GO:0006335) | 3.31580404 |
| 90 | cellular response to type I interferon (GO:0071357) | 3.31114674 |
| 91 | type I interferon signaling pathway (GO:0060337) | 3.31114674 |
| 92 | cotranslational protein targeting to membrane (GO:0006613) | 3.30472941 |
| 93 | B cell receptor signaling pathway (GO:0050853) | 3.29901989 |
| 94 | protein targeting to ER (GO:0045047) | 3.29513346 |
| 95 | regulation of mast cell activation (GO:0033003) | 3.29242324 |
| 96 | nucleobase biosynthetic process (GO:0046112) | 3.28247745 |
| 97 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.27952746 |
| 98 | response to host (GO:0075136) | 3.26464739 |
| 99 | response to host defenses (GO:0052200) | 3.26464739 |
| 100 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.26464739 |
| 101 | positive thymic T cell selection (GO:0045059) | 3.26381277 |
| 102 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.26108424 |
| 103 | regulation of helicase activity (GO:0051095) | 3.26095450 |
| 104 | neutrophil activation (GO:0042119) | 3.25558327 |
| 105 | positive regulation of mast cell degranulation (GO:0043306) | 3.22967856 |
| 106 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.22967856 |
| 107 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.21315072 |
| 108 | respiratory burst (GO:0045730) | 3.20745098 |
| 109 | viral mRNA export from host cell nucleus (GO:0046784) | 3.20378789 |
| 110 | negative regulation of type 2 immune response (GO:0002829) | 3.19192216 |
| 111 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.19043834 |
| 112 | macrophage activation (GO:0042116) | 3.18340583 |
| 113 | positive regulation of B cell differentiation (GO:0045579) | 3.18297505 |
| 114 | myeloid cell activation involved in immune response (GO:0002275) | 3.17530306 |
| 115 | positive regulation of interferon-alpha production (GO:0032727) | 3.16765320 |
| 116 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.14086900 |
| 117 | negative regulation of T cell mediated immunity (GO:0002710) | 3.12856559 |
| 118 | DNA replication initiation (GO:0006270) | 3.10602652 |
| 119 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.10365464 |
| 120 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.10277193 |
| 121 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.09787057 |
| 122 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.09787057 |
| 123 | granulocyte activation (GO:0036230) | 3.09419345 |
| 124 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.08901851 |
| 125 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.08758444 |
| 126 | DNA strand elongation (GO:0022616) | 3.08187703 |
| 127 | ribosomal large subunit biogenesis (GO:0042273) | 3.07241332 |
| 128 | tolerance induction (GO:0002507) | 3.04784228 |
| 129 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.03769278 |
| 130 | B cell mediated immunity (GO:0019724) | 3.03479058 |
| 131 | regulation of interferon-alpha production (GO:0032647) | 3.03311329 |
| 132 | negative thymic T cell selection (GO:0045060) | 3.03232606 |
| 133 | histone H4-K12 acetylation (GO:0043983) | 3.02543284 |
| 134 | regulation of antigen processing and presentation (GO:0002577) | 3.01246924 |
| 135 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 3.00926667 |
| 136 | pre-miRNA processing (GO:0031054) | 3.00727539 |
| 137 | defense response to protozoan (GO:0042832) | 3.00434939 |
| 138 | protein localization to endoplasmic reticulum (GO:0070972) | 2.99749189 |
| 139 | regulation of T cell tolerance induction (GO:0002664) | 2.99183118 |
| 140 | histone H4-K5 acetylation (GO:0043981) | 2.98633086 |
| 141 | histone H4-K8 acetylation (GO:0043982) | 2.98633086 |
| 142 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 2.98162747 |
| 143 | regulation of B cell differentiation (GO:0045577) | 2.97563734 |
| 144 | positive regulation of antigen processing and presentation (GO:0002579) | 2.95837374 |
| 145 | ncRNA 3-end processing (GO:0043628) | 2.95529882 |
| 146 | purine nucleobase biosynthetic process (GO:0009113) | 2.94933648 |
| 147 | cullin deneddylation (GO:0010388) | 2.94612953 |
| 148 | activated T cell proliferation (GO:0050798) | 2.91829516 |
| 149 | interferon-gamma secretion (GO:0072643) | 2.91556977 |
| 150 | negative regulation of mRNA processing (GO:0050686) | 2.89092673 |
| 151 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.89059217 |
| 152 | termination of RNA polymerase II transcription (GO:0006369) | 2.88035367 |
| 153 | regulation of regulated secretory pathway (GO:1903305) | 2.86926812 |
| 154 | snRNA metabolic process (GO:0016073) | 2.86394520 |
| 155 | spliceosomal complex assembly (GO:0000245) | 2.86249592 |
| 156 | regulation of tolerance induction (GO:0002643) | 2.86099065 |
| 157 | establishment of integrated proviral latency (GO:0075713) | 2.85141451 |
| 158 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.84920333 |
| 159 | neutrophil mediated immunity (GO:0002446) | 2.84786286 |
| 160 | negative T cell selection (GO:0043383) | 2.84277321 |
| 161 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.84258939 |
| 162 | positive regulation of RNA splicing (GO:0033120) | 2.83977658 |
| 163 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.83673989 |
| 164 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.82829169 |
| 165 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.82829169 |
| 166 | regulation of telomere maintenance via telomerase (GO:0032210) | 2.81635500 |
| 167 | mRNA catabolic process (GO:0006402) | 2.81276506 |
| 168 | ribosome assembly (GO:0042255) | 2.80030917 |
| 169 | T cell selection (GO:0045058) | 2.79402393 |
| 170 | transcription-coupled nucleotide-excision repair (GO:0006283) | 2.79297544 |
| 171 | negative regulation of innate immune response (GO:0045824) | 2.78985941 |
| 172 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.78592011 |
| 173 | response to interleukin-15 (GO:0070672) | 2.78505662 |
| 174 | negative regulation of histone modification (GO:0031057) | 2.77547105 |
| 175 | IMP biosynthetic process (GO:0006188) | 2.77522724 |
| 176 | RNA catabolic process (GO:0006401) | 2.77175678 |
| 177 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.75636311 |
| 178 | regulation of type 2 immune response (GO:0002828) | 2.75330564 |
| 179 | rRNA processing (GO:0006364) | 2.72924536 |
| 180 | termination of RNA polymerase III transcription (GO:0006386) | 2.70123655 |
| 181 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.70123655 |
| 182 | nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289) | 2.69676636 |
| 183 | protein deneddylation (GO:0000338) | 2.69329019 |
| 184 | RNA splicing (GO:0008380) | 2.67788551 |
| 185 | snRNA processing (GO:0016180) | 2.66967426 |
| 186 | negative regulation of telomerase activity (GO:0051974) | 2.65461935 |
| 187 | negative regulation of chromatin modification (GO:1903309) | 2.64017137 |
| 188 | peptidyl-arginine modification (GO:0018195) | 2.63272852 |
| 189 | telomere maintenance via telomere lengthening (GO:0010833) | 2.63100908 |
| 190 | regulation of hippo signaling (GO:0035330) | 2.62922243 |
| 191 | pyrimidine ribonucleoside triphosphate biosynthetic process (GO:0009209) | 2.62679948 |
| 192 | rRNA metabolic process (GO:0016072) | 2.60742408 |
| 193 | histone H2A monoubiquitination (GO:0035518) | 2.60130857 |
| 194 | IMP metabolic process (GO:0046040) | 2.60037350 |
| 195 | RNA export from nucleus (GO:0006405) | 2.59144327 |
| 196 | ribonucleoprotein complex assembly (GO:0022618) | 2.58660349 |
| 197 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.58540414 |
| 198 | DNA duplex unwinding (GO:0032508) | 2.58083334 |
| 199 | DNA-templated transcription, termination (GO:0006353) | 2.55672494 |
| 200 | postreplication repair (GO:0006301) | 2.54180394 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.45468047 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.99645556 |
| 3 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.47731799 |
| 4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.45062974 |
| 5 | * IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.25534751 |
| 6 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.23108504 |
| 7 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 3.22889651 |
| 8 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.13623649 |
| 9 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.07456361 |
| 10 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.04173038 |
| 11 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.99899104 |
| 12 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.98729198 |
| 13 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.85296326 |
| 14 | MYC_22102868_ChIP-Seq_BL_Human | 2.81929903 |
| 15 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.71819723 |
| 16 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.65297555 |
| 17 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.61997270 |
| 18 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.56937054 |
| 19 | * IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.53852006 |
| 20 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.46970166 |
| 21 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.46816581 |
| 22 | * ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.42888044 |
| 23 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.40338764 |
| 24 | MAF_26560356_Chip-Seq_TH1_Human | 2.35419516 |
| 25 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.35150950 |
| 26 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.34417843 |
| 27 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.34276411 |
| 28 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.27272694 |
| 29 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.25811065 |
| 30 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.25712352 |
| 31 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.25450296 |
| 32 | * CIITA_25753668_ChIP-Seq_RAJI_Human | 2.20734531 |
| 33 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.19729319 |
| 34 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.19030208 |
| 35 | * EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.18846457 |
| 36 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.18641444 |
| 37 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.17110452 |
| 38 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.13357972 |
| 39 | * IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.12333046 |
| 40 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.09596138 |
| 41 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.07997644 |
| 42 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.07856555 |
| 43 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.07193599 |
| 44 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.05767345 |
| 45 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.05480753 |
| 46 | * CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.02623725 |
| 47 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.02511197 |
| 48 | * GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.01847172 |
| 49 | SPI1_23127762_ChIP-Seq_K562_Human | 2.01265363 |
| 50 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 2.00263341 |
| 51 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 2.00263341 |
| 52 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 2.00263341 |
| 53 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.97517780 |
| 54 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.94333401 |
| 55 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.93126429 |
| 56 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.92134483 |
| 57 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.91764508 |
| 58 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.88809660 |
| 59 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.86686846 |
| 60 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.86529295 |
| 61 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.83257212 |
| 62 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.83056294 |
| 63 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.80586105 |
| 64 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.80388635 |
| 65 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.78990164 |
| 66 | * POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.78520182 |
| 67 | MYB_26560356_Chip-Seq_TH2_Human | 1.75817721 |
| 68 | * YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.73954026 |
| 69 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.73259003 |
| 70 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.72860690 |
| 71 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.72517982 |
| 72 | * NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.72168025 |
| 73 | MYB_26560356_Chip-Seq_TH1_Human | 1.69812304 |
| 74 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.69450124 |
| 75 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.69281470 |
| 76 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.63771515 |
| 77 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.60912397 |
| 78 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.60273891 |
| 79 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.60122002 |
| 80 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.58093636 |
| 81 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.57636873 |
| 82 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.56386063 |
| 83 | * ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.54697625 |
| 84 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 1.53434193 |
| 85 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.52438130 |
| 86 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.51933098 |
| 87 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.51299642 |
| 88 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.51258424 |
| 89 | * NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 1.49357348 |
| 90 | * YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.48935676 |
| 91 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.47562666 |
| 92 | * TTF2_22483619_ChIP-Seq_HELA_Human | 1.47234774 |
| 93 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.46592419 |
| 94 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.44491636 |
| 95 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.42868557 |
| 96 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.41440579 |
| 97 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.39621560 |
| 98 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.37955485 |
| 99 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.37160110 |
| 100 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.37081043 |
| 101 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.36718801 |
| 102 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.36545178 |
| 103 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.36319445 |
| 104 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.35556756 |
| 105 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.33756501 |
| 106 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.33542512 |
| 107 | * TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.32473013 |
| 108 | * NANOG_21062744_ChIP-ChIP_HESCs_Human | 1.31697933 |
| 109 | * GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.31251260 |
| 110 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.30202513 |
| 111 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.29610065 |
| 112 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.28909422 |
| 113 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.27450543 |
| 114 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.27435191 |
| 115 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.26979203 |
| 116 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.26970287 |
| 117 | KDM2B_26808549_Chip-Seq_K562_Human | 1.26429944 |
| 118 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.25566974 |
| 119 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.25364636 |
| 120 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.24736906 |
| 121 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.24409394 |
| 122 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.22056688 |
| 123 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.21918725 |
| 124 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.21723633 |
| 125 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.21127585 |
| 126 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.20717365 |
| 127 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.19796426 |
| 128 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 1.19560918 |
| 129 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.18384384 |
| 130 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.18337226 |
| 131 | * OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.17709409 |
| 132 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.17403878 |
| 133 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.17359327 |
| 134 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.16984966 |
| 135 | GATA1_19941826_ChIP-Seq_K562_Human | 1.16911517 |
| 136 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.14917195 |
| 137 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.13472755 |
| 138 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.13105071 |
| 139 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.12356612 |
| 140 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.12204584 |
| 141 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.10920830 |
| 142 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.10603571 |
| 143 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.09905368 |
| 144 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.09723385 |
| 145 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 1.08766956 |
| 146 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.07444213 |
| 147 | UTX_26944678_Chip-Seq_JUKART_Human | 1.06418563 |
| 148 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.06266035 |
| 149 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.05807695 |
| 150 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.05267058 |
| 151 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.05071889 |
| 152 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.04394411 |
| 153 | P68_20966046_ChIP-Seq_HELA_Human | 1.04260019 |
| 154 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.02699046 |
| 155 | * SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.02648893 |
| 156 | * ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.02609664 |
| 157 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.01864351 |
| 158 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.00665024 |
| 159 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.00188618 |
| 160 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.99473555 |
| 161 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.99178626 |
| 162 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.98624224 |
| 163 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 0.97994883 |
| 164 | MAF_26560356_Chip-Seq_TH2_Human | 0.97976857 |
| 165 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.97933118 |
| 166 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.97527963 |
| 167 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.96707602 |
| 168 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.96484149 |
| 169 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.96390194 |
| 170 | SOX2_18692474_ChIP-Seq_MESCs_Mouse | 0.96299061 |
| 171 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.96132445 |
| 172 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.94956096 |
| 173 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 0.94444280 |
| 174 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.94416905 |
| 175 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.94052765 |
| 176 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.93222878 |
| 177 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.92439562 |
| 178 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.90977625 |
| 179 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.89950549 |
| 180 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.89684719 |
| 181 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.89420169 |
| 182 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.87338717 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003724_increased_susceptibility_to | 4.59885571 |
| 2 | MP0003436_decreased_susceptibility_to | 4.10285459 |
| 3 | MP0003693_abnormal_embryo_hatching | 3.94843577 |
| 4 | MP0004957_abnormal_blastocyst_morpholog | 3.64657769 |
| 5 | MP0001835_abnormal_antigen_presentation | 3.57950538 |
| 6 | MP0001348_abnormal_lacrimal_gland | 3.50193623 |
| 7 | MP0003111_abnormal_nucleus_morphology | 3.31943452 |
| 8 | MP0003077_abnormal_cell_cycle | 3.19712099 |
| 9 | MP0005671_abnormal_response_to | 2.99950729 |
| 10 | MP0002419_abnormal_innate_immunity | 2.97527983 |
| 11 | MP0010094_abnormal_chromosome_stability | 2.95572876 |
| 12 | MP0005387_immune_system_phenotype | 2.90191686 |
| 13 | MP0001790_abnormal_immune_system | 2.90191686 |
| 14 | MP0005000_abnormal_immune_tolerance | 2.89223561 |
| 15 | MP0005025_abnormal_response_to | 2.80205853 |
| 16 | MP0006292_abnormal_olfactory_placode | 2.75923518 |
| 17 | MP0008007_abnormal_cellular_replicative | 2.64621341 |
| 18 | MP0004133_heterotaxia | 2.63105166 |
| 19 | MP0009785_altered_susceptibility_to | 2.62055960 |
| 20 | MP0002148_abnormal_hypersensitivity_rea | 2.49789661 |
| 21 | MP0008877_abnormal_DNA_methylation | 2.49099392 |
| 22 | MP0001730_embryonic_growth_arrest | 2.46600275 |
| 23 | MP0008058_abnormal_DNA_repair | 2.45884989 |
| 24 | MP0003300_gastrointestinal_ulcer | 2.35499806 |
| 25 | MP0006082_CNS_inflammation | 2.34721740 |
| 26 | MP0003172_abnormal_lysosome_physiology | 2.29575785 |
| 27 | MP0003119_abnormal_digestive_system | 2.23470409 |
| 28 | MP0005058_abnormal_lysosome_morphology | 2.21375547 |
| 29 | MP0002653_abnormal_ependyma_morphology | 2.14112821 |
| 30 | MP0001533_abnormal_skeleton_physiology | 2.11100054 |
| 31 | MP0000350_abnormal_cell_proliferation | 2.10823489 |
| 32 | MP0004947_skin_inflammation | 2.00885278 |
| 33 | MP0008932_abnormal_embryonic_tissue | 1.98722480 |
| 34 | MP0010155_abnormal_intestine_physiology | 1.89009758 |
| 35 | MP0002405_respiratory_system_inflammati | 1.87409912 |
| 36 | MP0008260_abnormal_autophagy | 1.86148531 |
| 37 | MP0008057_abnormal_DNA_replication | 1.85661360 |
| 38 | MP0009278_abnormal_bone_marrow | 1.84665588 |
| 39 | MP0003191_abnormal_cellular_cholesterol | 1.84063478 |
| 40 | MP0002085_abnormal_embryonic_tissue | 1.80378470 |
| 41 | MP0002084_abnormal_developmental_patter | 1.79675058 |
| 42 | MP0005464_abnormal_platelet_physiology | 1.78184239 |
| 43 | MP0001845_abnormal_inflammatory_respons | 1.72987279 |
| 44 | MP0010030_abnormal_orbit_morphology | 1.67288777 |
| 45 | MP0003121_genomic_imprinting | 1.67253592 |
| 46 | MP0002138_abnormal_hepatobiliary_system | 1.64722604 |
| 47 | MP0002751_abnormal_autonomic_nervous | 1.64081216 |
| 48 | * MP0002080_prenatal_lethality | 1.63788348 |
| 49 | MP0005380_embryogenesis_phenotype | 1.59968073 |
| 50 | MP0001672_abnormal_embryogenesis/_devel | 1.59968073 |
| 51 | MP0001697_abnormal_embryo_size | 1.59220740 |
| 52 | MP0000537_abnormal_urethra_morphology | 1.58696446 |
| 53 | MP0002396_abnormal_hematopoietic_system | 1.56823902 |
| 54 | MP0000313_abnormal_cell_death | 1.55911019 |
| 55 | MP0005310_abnormal_salivary_gland | 1.54095595 |
| 56 | MP0003828_pulmonary_edema | 1.53367548 |
| 57 | MP0003890_abnormal_embryonic-extraembry | 1.53122584 |
| 58 | MP0003861_abnormal_nervous_system | 1.48888073 |
| 59 | MP0003787_abnormal_imprinting | 1.48788823 |
| 60 | MP0009764_decreased_sensitivity_to | 1.48738052 |
| 61 | MP0001853_heart_inflammation | 1.48369045 |
| 62 | MP0001293_anophthalmia | 1.47403240 |
| 63 | MP0003183_abnormal_peptide_metabolism | 1.46295537 |
| 64 | MP0000778_abnormal_nervous_system | 1.45883523 |
| 65 | MP0002998_abnormal_bone_remodeling | 1.43222173 |
| 66 | MP0002398_abnormal_bone_marrow | 1.43140038 |
| 67 | MP0009333_abnormal_splenocyte_physiolog | 1.42801582 |
| 68 | MP0000703_abnormal_thymus_morphology | 1.41367764 |
| 69 | MP0005451_abnormal_body_composition | 1.40691975 |
| 70 | MP0003984_embryonic_growth_retardation | 1.39516879 |
| 71 | MP0002088_abnormal_embryonic_growth/wei | 1.38350005 |
| 72 | MP0009379_abnormal_foot_pigmentation | 1.36858789 |
| 73 | MP0003866_abnormal_defecation | 1.32628689 |
| 74 | MP0003786_premature_aging | 1.32376105 |
| 75 | MP0008469_abnormal_protein_level | 1.31842728 |
| 76 | MP0010352_gastrointestinal_tract_polyps | 1.31712840 |
| 77 | MP0000689_abnormal_spleen_morphology | 1.31472061 |
| 78 | MP0004510_myositis | 1.31384910 |
| 79 | MP0002132_abnormal_respiratory_system | 1.31364259 |
| 80 | MP0005076_abnormal_cell_differentiation | 1.30323442 |
| 81 | MP0004197_abnormal_fetal_growth/weight/ | 1.29671533 |
| 82 | MP0000604_amyloidosis | 1.29270506 |
| 83 | MP0008789_abnormal_olfactory_epithelium | 1.29143919 |
| 84 | MP0008995_early_reproductive_senescence | 1.26574658 |
| 85 | MP0003123_paternal_imprinting | 1.25536887 |
| 86 | MP0002019_abnormal_tumor_incidence | 1.24326554 |
| 87 | MP0004185_abnormal_adipocyte_glucose | 1.21979805 |
| 88 | MP0002722_abnormal_immune_system | 1.21280590 |
| 89 | MP0004130_abnormal_muscle_cell | 1.19779848 |
| 90 | MP0003221_abnormal_cardiomyocyte_apopto | 1.18998835 |
| 91 | MP0004381_abnormal_hair_follicle | 1.17273994 |
| 92 | MP0000716_abnormal_immune_system | 1.15742273 |
| 93 | MP0001800_abnormal_humoral_immune | 1.15586642 |
| 94 | MP0003763_abnormal_thymus_physiology | 1.14591205 |
| 95 | MP0005394_taste/olfaction_phenotype | 1.14139903 |
| 96 | MP0005499_abnormal_olfactory_system | 1.14139903 |
| 97 | MP0003075_altered_response_to | 1.14060660 |
| 98 | MP0002086_abnormal_extraembryonic_tissu | 1.12738007 |
| 99 | MP0002429_abnormal_blood_cell | 1.11055283 |
| 100 | MP0000490_abnormal_crypts_of | 1.09712621 |
| 101 | MP0003690_abnormal_glial_cell | 1.07936390 |
| 102 | MP0005174_abnormal_tail_pigmentation | 1.07934279 |
| 103 | MP0000685_abnormal_immune_system | 1.06788290 |
| 104 | MP0003315_abnormal_perineum_morphology | 1.02804846 |
| 105 | MP0000465_gastrointestinal_hemorrhage | 1.00860793 |
| 106 | MP0000343_altered_response_to | 1.00776432 |
| 107 | MP0002092_abnormal_eye_morphology | 1.00518262 |
| 108 | MP0001849_ear_inflammation | 1.00472658 |
| 109 | MP0002420_abnormal_adaptive_immunity | 0.98411075 |
| 110 | MP0001851_eye_inflammation | 0.97667417 |
| 111 | MP0001819_abnormal_immune_cell | 0.96659464 |
| 112 | MP0005390_skeleton_phenotype | 0.96008122 |
| 113 | MP0005166_decreased_susceptibility_to | 0.95495099 |
| 114 | MP0002166_altered_tumor_susceptibility | 0.95351585 |
| 115 | MP0002277_abnormal_respiratory_mucosa | 0.91966431 |
| 116 | MP0002933_joint_inflammation | 0.91374140 |
| 117 | MP0009672_abnormal_birth_weight | 0.90268078 |
| 118 | MP0002452_abnormal_antigen_presenting | 0.90052322 |
| 119 | MP0002111_abnormal_tail_morphology | 0.89680069 |
| 120 | MP0003656_abnormal_erythrocyte_physiolo | 0.89526708 |
| 121 | MP0002152_abnormal_brain_morphology | 0.89388534 |
| 122 | MP0003938_abnormal_ear_development | 0.89003827 |
| 123 | MP0003283_abnormal_digestive_organ | 0.87975308 |
| 124 | MP0000858_altered_metastatic_potential | 0.87680969 |
| 125 | MP0001873_stomach_inflammation | 0.87073666 |
| 126 | MP0005379_endocrine/exocrine_gland_phen | 0.85673023 |
| 127 | MP0010307_abnormal_tumor_latency | 0.85007913 |
| 128 | MP0002160_abnormal_reproductive_system | 0.83927792 |
| 129 | MP0000678_abnormal_parathyroid_gland | 0.83804089 |
| 130 | MP0003115_abnormal_respiratory_system | 0.82833241 |
| 131 | MP0004883_abnormal_blood_vessel | 0.81950594 |
| 132 | MP0004808_abnormal_hematopoietic_stem | 0.81300565 |
| 133 | MP0001663_abnormal_digestive_system | 0.80911820 |
| 134 | MP0009765_abnormal_xenobiotic_induced | 0.80821388 |
| 135 | MP0004811_abnormal_neuron_physiology | 0.80587230 |
| 136 | MP0003303_peritoneal_inflammation | 0.80286590 |
| 137 | MP0005075_abnormal_melanosome_morpholog | 0.80048874 |
| 138 | MP0003448_altered_tumor_morphology | 0.79954407 |
| 139 | MP0001145_abnormal_male_reproductive | 0.77101000 |
| 140 | MP0001915_intracranial_hemorrhage | 0.77020783 |
| 141 | MP0009840_abnormal_foam_cell | 0.76837426 |
| 142 | MP0002081_perinatal_lethality | 0.76544435 |
| 143 | MP0002723_abnormal_immune_serum | 0.76532529 |
| 144 | MP0003567_abnormal_fetal_cardiomyocyte | 0.76526363 |
| 145 | MP0009763_increased_sensitivity_to | 0.73892330 |
| 146 | MP0002210_abnormal_sex_determination | 0.73699999 |
| 147 | MP0002075_abnormal_coat/hair_pigmentati | 0.73201070 |
| 148 | MP0000371_diluted_coat_color | 0.72730247 |
| 149 | MP0005384_cellular_phenotype | 0.70682701 |
| 150 | MP0005389_reproductive_system_phenotype | 0.69988358 |
| 151 | MP0005397_hematopoietic_system_phenotyp | 0.69738946 |
| 152 | MP0001545_abnormal_hematopoietic_system | 0.69738946 |
| 153 | MP0000631_abnormal_neuroendocrine_gland | 0.68738150 |
| 154 | MP0001286_abnormal_eye_development | 0.68348849 |
| 155 | MP0002139_abnormal_hepatobiliary_system | 0.67842599 |
| 156 | MP0000428_abnormal_craniofacial_morphol | 0.67803861 |
| 157 | MP0003795_abnormal_bone_structure | 0.67587497 |
| 158 | MP0003329_amyloid_beta_deposits | 0.67092761 |
| 159 | MP0000477_abnormal_intestine_morphology | 0.66832048 |
| 160 | MP0005164_abnormal_response_to | 0.66000474 |
| 161 | MP0003453_abnormal_keratinocyte_physiol | 0.65981009 |
| 162 | MP0005167_abnormal_blood-brain_barrier | 0.65309947 |
| 163 | MP0005083_abnormal_biliary_tract | 0.62966154 |
| 164 | MP0000681_abnormal_thyroid_gland | 0.62648176 |
| 165 | MP0002133_abnormal_respiratory_system | 0.61607747 |
| 166 | MP0005388_respiratory_system_phenotype | 0.61607747 |
| 167 | MP0000249_abnormal_blood_vessel | 0.61000675 |
| 168 | MP0008874_decreased_physiological_sensi | 0.60888209 |
| 169 | MP0005666_abnormal_adipose_tissue | 0.56932833 |
| 170 | MP0003091_abnormal_cell_migration | 0.56905115 |
| 171 | MP0003705_abnormal_hypodermis_morpholog | 0.56151033 |
| 172 | MP0004858_abnormal_nervous_system | 0.55685596 |
| 173 | MP0003879_abnormal_hair_cell | 0.54732511 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 6.06293124 |
| 2 | Recurrent bacterial skin infections (HP:0005406) | 5.32985216 |
| 3 | Recurrent abscess formation (HP:0002722) | 5.32343865 |
| 4 | Abnormality of macrophages (HP:0004311) | 4.66281224 |
| 5 | Colon cancer (HP:0003003) | 4.52349655 |
| 6 | Myositis (HP:0100614) | 4.51741769 |
| 7 | Ependymoma (HP:0002888) | 4.44796181 |
| 8 | Mediastinal lymphadenopathy (HP:0100721) | 4.39589299 |
| 9 | Agnosia (HP:0010524) | 4.27663508 |
| 10 | Orchitis (HP:0100796) | 4.09893321 |
| 11 | Amyotrophic lateral sclerosis (HP:0007354) | 4.04844707 |
| 12 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.03333952 |
| 13 | Medulloblastoma (HP:0002885) | 3.83783655 |
| 14 | Optic neuritis (HP:0100653) | 3.82329918 |
| 15 | Retrobulbar optic neuritis (HP:0100654) | 3.82329918 |
| 16 | Recurrent fungal infections (HP:0002841) | 3.70335762 |
| 17 | Spontaneous hematomas (HP:0007420) | 3.56762183 |
| 18 | Meningitis (HP:0001287) | 3.53248854 |
| 19 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.44243127 |
| 20 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.42408674 |
| 21 | Cerebral hypomyelination (HP:0006808) | 3.38674974 |
| 22 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 3.38062580 |
| 23 | Reticulocytopenia (HP:0001896) | 3.37155319 |
| 24 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.35182781 |
| 25 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.35182781 |
| 26 | Abnormality of glycolipid metabolism (HP:0010969) | 3.35182781 |
| 27 | Recurrent skin infections (HP:0001581) | 3.33463399 |
| 28 | Patellar aplasia (HP:0006443) | 3.32703409 |
| 29 | Gingivitis (HP:0000230) | 3.30603359 |
| 30 | Stomatitis (HP:0010280) | 3.30477325 |
| 31 | Obstructive lung disease (HP:0006536) | 3.25919753 |
| 32 | Chronic obstructive pulmonary disease (HP:0006510) | 3.25919753 |
| 33 | Gastrointestinal infarctions (HP:0005244) | 3.16685736 |
| 34 | Astrocytoma (HP:0009592) | 3.16043814 |
| 35 | Abnormality of the astrocytes (HP:0100707) | 3.16043814 |
| 36 | Increased IgE level (HP:0003212) | 3.06571766 |
| 37 | Vasculitis (HP:0002633) | 3.01850743 |
| 38 | Aplasia/Hypoplasia of the patella (HP:0006498) | 3.00382714 |
| 39 | Recurrent viral infections (HP:0004429) | 2.98071037 |
| 40 | Pulmonary infiltrates (HP:0002113) | 2.90704517 |
| 41 | Encephalitis (HP:0002383) | 2.88506846 |
| 42 | Hyperacusis (HP:0010780) | 2.88276293 |
| 43 | Absent thumb (HP:0009777) | 2.86945645 |
| 44 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.84309380 |
| 45 | Recurrent cutaneous fungal infections (HP:0011370) | 2.84309380 |
| 46 | Urticaria (HP:0001025) | 2.82641475 |
| 47 | Broad alveolar ridges (HP:0000187) | 2.81029045 |
| 48 | Panhypogammaglobulinemia (HP:0003139) | 2.80450008 |
| 49 | Keratoconjunctivitis sicca (HP:0001097) | 2.78462166 |
| 50 | Multiple enchondromatosis (HP:0005701) | 2.75683882 |
| 51 | Dysostosis multiplex (HP:0000943) | 2.71827921 |
| 52 | Colitis (HP:0002583) | 2.71783536 |
| 53 | Increased cerebral lipofuscin (HP:0011813) | 2.70561941 |
| 54 | Basal cell carcinoma (HP:0002671) | 2.70360521 |
| 55 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.69953178 |
| 56 | Aplasia/Hypoplasia of the sternum (HP:0006714) | 2.68156551 |
| 57 | Neoplasm of the oral cavity (HP:0100649) | 2.67026923 |
| 58 | Hemoptysis (HP:0002105) | 2.64181216 |
| 59 | Papilloma (HP:0012740) | 2.63310545 |
| 60 | Verrucae (HP:0200043) | 2.63310545 |
| 61 | Chest pain (HP:0100749) | 2.59240593 |
| 62 | Spinal muscular atrophy (HP:0007269) | 2.58321750 |
| 63 | Abnormality of the anterior horn cell (HP:0006802) | 2.57291137 |
| 64 | Degeneration of anterior horn cells (HP:0002398) | 2.57291137 |
| 65 | Systemic lupus erythematosus (HP:0002725) | 2.53849297 |
| 66 | Gastrointestinal inflammation (HP:0004386) | 2.52522601 |
| 67 | Granulocytopenia (HP:0001913) | 2.51283642 |
| 68 | Leukocytosis (HP:0001974) | 2.50336223 |
| 69 | Hypochromic anemia (HP:0001931) | 2.49109502 |
| 70 | Keratoconjunctivitis (HP:0001096) | 2.48718794 |
| 71 | Inflammation of the large intestine (HP:0002037) | 2.47324664 |
| 72 | Disinhibition (HP:0000734) | 2.44274811 |
| 73 | Increased nuchal translucency (HP:0010880) | 2.43081359 |
| 74 | Renal duplication (HP:0000075) | 2.42556362 |
| 75 | Abnormality of the intervertebral disk (HP:0005108) | 2.41888869 |
| 76 | Autoimmune thrombocytopenia (HP:0001973) | 2.41694787 |
| 77 | Agammaglobulinemia (HP:0004432) | 2.41440683 |
| 78 | Abnormality of T cell number (HP:0011839) | 2.38156634 |
| 79 | Gastrointestinal stroma tumor (HP:0100723) | 2.38023615 |
| 80 | T lymphocytopenia (HP:0005403) | 2.37949163 |
| 81 | Abnormal neuron morphology (HP:0012757) | 2.36930627 |
| 82 | Abnormality of the motor neurons (HP:0002450) | 2.36930627 |
| 83 | Osteomyelitis (HP:0002754) | 2.35872102 |
| 84 | Pustule (HP:0200039) | 2.34313507 |
| 85 | Prolonged bleeding time (HP:0003010) | 2.33440073 |
| 86 | Visual hallucinations (HP:0002367) | 2.32188979 |
| 87 | Increased IgM level (HP:0003496) | 2.31576783 |
| 88 | Overriding aorta (HP:0002623) | 2.31079902 |
| 89 | Neoplasm of the pancreas (HP:0002894) | 2.30653690 |
| 90 | Glioma (HP:0009733) | 2.29504743 |
| 91 | Polygenic inheritance (HP:0010982) | 2.26865785 |
| 92 | Abnormal number of erythroid precursors (HP:0012131) | 2.26317164 |
| 93 | Adenoma sebaceum (HP:0009720) | 2.25468306 |
| 94 | Angiofibromas (HP:0010615) | 2.25468306 |
| 95 | Arterial thrombosis (HP:0004420) | 2.23627198 |
| 96 | Restrictive lung disease (HP:0002091) | 2.23471615 |
| 97 | Glossoptosis (HP:0000162) | 2.22647179 |
| 98 | Abnormality of the labia minora (HP:0012880) | 2.22503799 |
| 99 | Amyloidosis (HP:0011034) | 2.21679115 |
| 100 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.19144196 |
| 101 | Hematochezia (HP:0002573) | 2.18787971 |
| 102 | Lymphopenia (HP:0001888) | 2.17386997 |
| 103 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.17300475 |
| 104 | Pulmonary embolism (HP:0002204) | 2.16081491 |
| 105 | Eosinophilia (HP:0001880) | 2.15577834 |
| 106 | Insomnia (HP:0100785) | 2.15524939 |
| 107 | Loss of speech (HP:0002371) | 2.15394160 |
| 108 | Abnormality of the salivary glands (HP:0010286) | 2.14942438 |
| 109 | Selective tooth agenesis (HP:0001592) | 2.13717000 |
| 110 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.13538066 |
| 111 | Sepsis (HP:0100806) | 2.13032867 |
| 112 | Cellulitis (HP:0100658) | 2.11953879 |
| 113 | Trismus (HP:0000211) | 2.11573137 |
| 114 | CNS hypomyelination (HP:0003429) | 2.11305122 |
| 115 | Macrocytic anemia (HP:0001972) | 2.11036770 |
| 116 | Purpura (HP:0000979) | 2.10613731 |
| 117 | Breast hypoplasia (HP:0003187) | 2.10328611 |
| 118 | Elfin facies (HP:0004428) | 2.09986449 |
| 119 | Abnormality of the lower motor neuron (HP:0002366) | 2.08795934 |
| 120 | Rhabdomyosarcoma (HP:0002859) | 2.06497715 |
| 121 | Amaurosis fugax (HP:0100576) | 2.06370003 |
| 122 | Orthostatic hypotension (HP:0001278) | 2.05952184 |
| 123 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.05620712 |
| 124 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.05620712 |
| 125 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.05620712 |
| 126 | Slow saccadic eye movements (HP:0000514) | 2.05475798 |
| 127 | Epistaxis (HP:0000421) | 2.05463258 |
| 128 | Abnormality of T cells (HP:0002843) | 2.04486196 |
| 129 | Asplenia (HP:0001746) | 2.04406248 |
| 130 | Spina bifida occulta (HP:0003298) | 2.04101325 |
| 131 | Interstitial pulmonary disease (HP:0006530) | 2.03819447 |
| 132 | Cutaneous melanoma (HP:0012056) | 2.03627597 |
| 133 | Increased serum ferritin (HP:0003281) | 2.02860438 |
| 134 | Mucopolysacchariduria (HP:0008155) | 2.02630955 |
| 135 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.02630955 |
| 136 | Horseshoe kidney (HP:0000085) | 2.00976824 |
| 137 | Porencephaly (HP:0002132) | 2.00972352 |
| 138 | Abnormality of the pleura (HP:0002103) | 1.99394672 |
| 139 | Birth length less than 3rd percentile (HP:0003561) | 1.98042878 |
| 140 | Pathologic fracture (HP:0002756) | 1.96701912 |
| 141 | Malignant gastrointestinal tract tumors (HP:0006749) | 1.96688713 |
| 142 | Gastrointestinal carcinoma (HP:0002672) | 1.96688713 |
| 143 | Hypergammaglobulinemia (HP:0010702) | 1.96239520 |
| 144 | Facial hemangioma (HP:0000329) | 1.96037533 |
| 145 | Anorexia (HP:0002039) | 1.95509010 |
| 146 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 1.93933034 |
| 147 | Hemiplegia (HP:0002301) | 1.93755436 |
| 148 | Viral hepatitis (HP:0006562) | 1.93110155 |
| 149 | Tracheoesophageal fistula (HP:0002575) | 1.92668322 |
| 150 | Sex reversal (HP:0012245) | 1.92512729 |
| 151 | Abnormal sex determination (HP:0012244) | 1.92512729 |
| 152 | Petechiae (HP:0000967) | 1.92301443 |
| 153 | Poikiloderma (HP:0001029) | 1.91428869 |
| 154 | Emphysema (HP:0002097) | 1.90787518 |
| 155 | Acute lymphatic leukemia (HP:0006721) | 1.90750974 |
| 156 | Ankle contracture (HP:0006466) | 1.89936662 |
| 157 | Hypermelanotic macule (HP:0001034) | 1.89889523 |
| 158 | Abnormal lung lobation (HP:0002101) | 1.89457176 |
| 159 | Cutis marmorata (HP:0000965) | 1.89187003 |
| 160 | Gingival bleeding (HP:0000225) | 1.88930177 |
| 161 | Renovascular hypertension (HP:0100817) | 1.88750576 |
| 162 | Episodic fever (HP:0001954) | 1.88323315 |
| 163 | Recurrent pneumonia (HP:0006532) | 1.88095280 |
| 164 | Impulsivity (HP:0100710) | 1.87705458 |
| 165 | Malnutrition (HP:0004395) | 1.87561808 |
| 166 | Freckling (HP:0001480) | 1.87160716 |
| 167 | Abnormality of hair growth rate (HP:0011363) | 1.86765709 |
| 168 | Slow-growing hair (HP:0002217) | 1.86765709 |
| 169 | Pallor (HP:0000980) | 1.86268793 |
| 170 | Hypochromic microcytic anemia (HP:0004840) | 1.85820451 |
| 171 | Autoimmune hemolytic anemia (HP:0001890) | 1.85375147 |
| 172 | Diminished motivation (HP:0000745) | 1.84223475 |
| 173 | Personality changes (HP:0000751) | 1.82777239 |
| 174 | Missing ribs (HP:0000921) | 1.80585882 |
| 175 | Wrist flexion contracture (HP:0001239) | 1.79170926 |
| 176 | High anterior hairline (HP:0009890) | 1.75640355 |
| 177 | Premature graying of hair (HP:0002216) | 1.73845214 |
| 178 | Tongue fasciculations (HP:0001308) | 1.73792805 |
| 179 | Neoplasm of striated muscle (HP:0009728) | 1.71887232 |
| 180 | Deep palmar crease (HP:0006191) | 1.69653232 |
| 181 | Chronic otitis media (HP:0000389) | 1.69411018 |
| 182 | Supernumerary spleens (HP:0009799) | 1.69249533 |
| 183 | Optic nerve coloboma (HP:0000588) | 1.68510215 |
| 184 | Absent radius (HP:0003974) | 1.68181402 |
| 185 | Apathy (HP:0000741) | 1.68053297 |
| 186 | Myelodysplasia (HP:0002863) | 1.66038603 |
| 187 | Short 4th metacarpal (HP:0010044) | 1.65213636 |
| 188 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 1.65213636 |
| 189 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.64876899 |
| 190 | Proximal placement of thumb (HP:0009623) | 1.64693879 |
| 191 | Peripheral hypomyelination (HP:0007182) | 1.64678375 |
| 192 | Abnormality of the diencephalon (HP:0010662) | 1.63034599 |
| 193 | Shoulder girdle muscle weakness (HP:0003547) | 1.62547560 |
| 194 | Progressive muscle weakness (HP:0003323) | 1.61726611 |
| 195 | Recurrent bronchitis (HP:0002837) | 1.61674571 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BUB1 | 4.07336535 |
| 2 | RIPK4 | 3.95193191 |
| 3 | MAP3K10 | 3.59955526 |
| 4 | EEF2K | 3.37870759 |
| 5 | TESK2 | 3.20940468 |
| 6 | ERN1 | 3.06239718 |
| 7 | TSSK6 | 2.81068933 |
| 8 | ICK | 2.73901704 |
| 9 | MAP2K3 | 2.66340553 |
| 10 | IRAK4 | 2.48590866 |
| 11 | TYK2 | 2.33027060 |
| 12 | PKN2 | 2.28919648 |
| 13 | MARK1 | 2.28834854 |
| 14 | GRK6 | 2.14565298 |
| 15 | DYRK2 | 2.11987530 |
| 16 | DYRK3 | 1.96892740 |
| 17 | BLK | 1.95284638 |
| 18 | SRPK1 | 1.91755175 |
| 19 | MAP4K1 | 1.91350592 |
| 20 | CDC7 | 1.89795666 |
| 21 | PRKD2 | 1.89115898 |
| 22 | ZAP70 | 1.87246890 |
| 23 | PASK | 1.86677596 |
| 24 | SMG1 | 1.83568310 |
| 25 | MAP3K14 | 1.82389222 |
| 26 | CDK19 | 1.77750224 |
| 27 | WEE1 | 1.68604511 |
| 28 | PAK4 | 1.66374708 |
| 29 | TBK1 | 1.64495389 |
| 30 | PRPF4B | 1.62673842 |
| 31 | EPHB1 | 1.60784183 |
| 32 | LRRK2 | 1.59717097 |
| 33 | MAP3K11 | 1.58496266 |
| 34 | EPHA2 | 1.58482528 |
| 35 | NEK2 | 1.57640742 |
| 36 | UHMK1 | 1.55245835 |
| 37 | CDK7 | 1.54488611 |
| 38 | RPS6KB2 | 1.51191659 |
| 39 | CDK12 | 1.49995975 |
| 40 | CSF1R | 1.48773581 |
| 41 | JAK3 | 1.48095140 |
| 42 | TNK2 | 1.44841316 |
| 43 | IKBKE | 1.44129337 |
| 44 | TRIB3 | 1.43988731 |
| 45 | MAP3K13 | 1.43785951 |
| 46 | TAOK1 | 1.42637304 |
| 47 | MAP3K3 | 1.40453240 |
| 48 | STK10 | 1.37611602 |
| 49 | MKNK1 | 1.31044931 |
| 50 | TXK | 1.29508651 |
| 51 | TLK1 | 1.27791821 |
| 52 | STK24 | 1.26623955 |
| 53 | LYN | 1.25519986 |
| 54 | MARK2 | 1.24731248 |
| 55 | DYRK1B | 1.21087629 |
| 56 | SIK1 | 1.17209872 |
| 57 | ALK | 1.17163546 |
| 58 | MAP3K8 | 1.15220061 |
| 59 | NEK1 | 1.15066251 |
| 60 | SIK3 | 1.13539768 |
| 61 | JAK1 | 1.13101202 |
| 62 | MAP3K1 | 1.12137842 |
| 63 | PLK1 | 1.11073885 |
| 64 | IKBKB | 1.11016577 |
| 65 | TGFBR1 | 1.08373993 |
| 66 | JAK2 | 1.04100450 |
| 67 | LCK | 1.01708298 |
| 68 | TAOK2 | 1.00978855 |
| 69 | TAOK3 | 1.00646998 |
| 70 | SCYL2 | 1.00134116 |
| 71 | RIPK1 | 0.98944915 |
| 72 | MATK | 0.98082741 |
| 73 | FGFR4 | 0.97771769 |
| 74 | ATR | 0.97729858 |
| 75 | SIK2 | 0.96083650 |
| 76 | MAP3K6 | 0.94859806 |
| 77 | LIMK1 | 0.94519514 |
| 78 | CDK4 | 0.94096081 |
| 79 | VRK1 | 0.93181007 |
| 80 | IRAK3 | 0.91097712 |
| 81 | YES1 | 0.89387807 |
| 82 | RPS6KA4 | 0.88964041 |
| 83 | FLT3 | 0.88843790 |
| 84 | TYRO3 | 0.87943306 |
| 85 | EIF2AK1 | 0.84129017 |
| 86 | IRAK2 | 0.84072555 |
| 87 | AURKA | 0.82176269 |
| 88 | PLK3 | 0.82017670 |
| 89 | ITK | 0.81963509 |
| 90 | PAK1 | 0.81533503 |
| 91 | EPHA3 | 0.81190112 |
| 92 | PDPK1 | 0.81063025 |
| 93 | CHEK1 | 0.78821422 |
| 94 | IRAK1 | 0.78483081 |
| 95 | CDC42BPA | 0.78389366 |
| 96 | CDK2 | 0.76493180 |
| 97 | HIPK2 | 0.75936512 |
| 98 | RPS6KL1 | 0.75894485 |
| 99 | MARK3 | 0.75448982 |
| 100 | MAPK12 | 0.75124971 |
| 101 | PDK1 | 0.74166189 |
| 102 | DAPK1 | 0.73645961 |
| 103 | CAMKK1 | 0.73590072 |
| 104 | KSR2 | 0.72870167 |
| 105 | NME2 | 0.69501306 |
| 106 | TTK | 0.68686468 |
| 107 | BTK | 0.66607908 |
| 108 | MAP2K4 | 0.65807459 |
| 109 | PRKCI | 0.64844150 |
| 110 | FGFR3 | 0.64261207 |
| 111 | AURKB | 0.63855816 |
| 112 | STK4 | 0.63636521 |
| 113 | GRK7 | 0.63196809 |
| 114 | TEC | 0.62631893 |
| 115 | RPS6KA6 | 0.61650388 |
| 116 | MAP3K7 | 0.61552292 |
| 117 | CLK1 | 0.61339940 |
| 118 | FGR | 0.61312232 |
| 119 | CSNK1G3 | 0.61103446 |
| 120 | BRSK1 | 0.60981012 |
| 121 | FYN | 0.59566499 |
| 122 | ILK | 0.58628198 |
| 123 | BCKDK | 0.57617769 |
| 124 | MAPK7 | 0.57036162 |
| 125 | SGK3 | 0.56982805 |
| 126 | BMPR2 | 0.56726064 |
| 127 | RPS6KA2 | 0.55777886 |
| 128 | MAP2K2 | 0.55152412 |
| 129 | RPS6KA1 | 0.54801566 |
| 130 | KIT | 0.54544815 |
| 131 | RPS6KA5 | 0.53983380 |
| 132 | PIM1 | 0.53859582 |
| 133 | SYK | 0.53417321 |
| 134 | RET | 0.52316913 |
| 135 | CSNK2A2 | 0.51447394 |
| 136 | BMX | 0.51136323 |
| 137 | CAMKK2 | 0.51048052 |
| 138 | CDK1 | 0.50019579 |
| 139 | MTOR | 0.49577299 |
| 140 | PTK6 | 0.48629176 |
| 141 | DAPK3 | 0.47412666 |
| 142 | TGFBR2 | 0.45283396 |
| 143 | STK11 | 0.45222260 |
| 144 | MAPK9 | 0.43157275 |
| 145 | FES | 0.42879005 |
| 146 | PNCK | 0.42460615 |
| 147 | STK16 | 0.41742398 |
| 148 | MAPK4 | 0.40951073 |
| 149 | ROCK2 | 0.40725680 |
| 150 | CHEK2 | 0.39109569 |
| 151 | CSNK1E | 0.38349453 |
| 152 | PRKD1 | 0.38149304 |
| 153 | MAPKAPK2 | 0.37125356 |
| 154 | CDK11A | 0.36841756 |
| 155 | PRKCH | 0.36116180 |
| 156 | TESK1 | 0.35566678 |
| 157 | MAPKAPK3 | 0.34898123 |
| 158 | MAP2K6 | 0.33946024 |
| 159 | NEK9 | 0.33855187 |
| 160 | DAPK2 | 0.33736540 |
| 161 | KSR1 | 0.33653150 |
| 162 | EIF2AK3 | 0.33162539 |
| 163 | CSK | 0.33147707 |
| 164 | MAPK11 | 0.33063621 |
| 165 | HCK | 0.33048744 |
| 166 | BRD4 | 0.31935135 |
| 167 | MAPK13 | 0.31126350 |
| 168 | RPS6KC1 | 0.31085789 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Spliceosome_Homo sapiens_hsa03040 | 4.06934054 |
| 2 | Mismatch repair_Homo sapiens_hsa03430 | 3.79669087 |
| 3 | Ribosome_Homo sapiens_hsa03010 | 3.56676079 |
| 4 | DNA replication_Homo sapiens_hsa03030 | 3.50791645 |
| 5 | RNA polymerase_Homo sapiens_hsa03020 | 3.41891321 |
| 6 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.92277759 |
| 7 | Base excision repair_Homo sapiens_hsa03410 | 2.85850806 |
| 8 | RNA transport_Homo sapiens_hsa03013 | 2.78673126 |
| 9 | Proteasome_Homo sapiens_hsa03050 | 2.76552722 |
| 10 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.73749530 |
| 11 | Leishmaniasis_Homo sapiens_hsa05140 | 2.64762674 |
| 12 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.57201422 |
| 13 | Allograft rejection_Homo sapiens_hsa05330 | 2.32688626 |
| 14 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.20819362 |
| 15 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.20486784 |
| 16 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 2.19102805 |
| 17 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.18215258 |
| 18 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.16907086 |
| 19 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.94057170 |
| 20 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.93125170 |
| 21 | Tuberculosis_Homo sapiens_hsa05152 | 1.92602992 |
| 22 | Homologous recombination_Homo sapiens_hsa03440 | 1.91339645 |
| 23 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.85757653 |
| 24 | Cell cycle_Homo sapiens_hsa04110 | 1.84188851 |
| 25 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.76171564 |
| 26 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.75151191 |
| 27 | Asthma_Homo sapiens_hsa05310 | 1.75083430 |
| 28 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.70622756 |
| 29 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.67575469 |
| 30 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.66913935 |
| 31 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.59719028 |
| 32 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.59376842 |
| 33 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.55438878 |
| 34 | Colorectal cancer_Homo sapiens_hsa05210 | 1.51022401 |
| 35 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.48539140 |
| 36 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.47614051 |
| 37 | Malaria_Homo sapiens_hsa05144 | 1.42389167 |
| 38 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.40722825 |
| 39 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.40231221 |
| 40 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.37084094 |
| 41 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.34026625 |
| 42 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.33281339 |
| 43 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.30008054 |
| 44 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.25474157 |
| 45 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.25158018 |
| 46 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.23200691 |
| 47 | RNA degradation_Homo sapiens_hsa03018 | 1.21545197 |
| 48 | Phagosome_Homo sapiens_hsa04145 | 1.19241053 |
| 49 | Basal transcription factors_Homo sapiens_hsa03022 | 1.17948861 |
| 50 | Endometrial cancer_Homo sapiens_hsa05213 | 1.17203983 |
| 51 | Basal cell carcinoma_Homo sapiens_hsa05217 | 1.14675367 |
| 52 | Lysosome_Homo sapiens_hsa04142 | 1.13983424 |
| 53 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.13016589 |
| 54 | Hepatitis C_Homo sapiens_hsa05160 | 1.11853485 |
| 55 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.11495604 |
| 56 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 1.09417381 |
| 57 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.01894524 |
| 58 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.99645989 |
| 59 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.99473882 |
| 60 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.98100441 |
| 61 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.97712372 |
| 62 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.95391462 |
| 63 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.93178636 |
| 64 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.92168812 |
| 65 | Shigellosis_Homo sapiens_hsa05131 | 0.91088240 |
| 66 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.91063342 |
| 67 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.88716526 |
| 68 | HTLV-I infection_Homo sapiens_hsa05166 | 0.86727839 |
| 69 | Apoptosis_Homo sapiens_hsa04210 | 0.85880808 |
| 70 | Platelet activation_Homo sapiens_hsa04611 | 0.85444058 |
| 71 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.85422535 |
| 72 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.84619509 |
| 73 | Alcoholism_Homo sapiens_hsa05034 | 0.83364489 |
| 74 | Purine metabolism_Homo sapiens_hsa00230 | 0.82323697 |
| 75 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.82261015 |
| 76 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.81562459 |
| 77 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.81162653 |
| 78 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.79555675 |
| 79 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.79325223 |
| 80 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.78902616 |
| 81 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.78738390 |
| 82 | Salmonella infection_Homo sapiens_hsa05132 | 0.78146240 |
| 83 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.77990787 |
| 84 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.75878543 |
| 85 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.72415594 |
| 86 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.71973824 |
| 87 | Thyroid cancer_Homo sapiens_hsa05216 | 0.70311875 |
| 88 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.70198410 |
| 89 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.69867334 |
| 90 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.68618236 |
| 91 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.67603338 |
| 92 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.67401384 |
| 93 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.67326529 |
| 94 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.67195682 |
| 95 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.65025474 |
| 96 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.64630201 |
| 97 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.63455116 |
| 98 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.62977938 |
| 99 | Pathways in cancer_Homo sapiens_hsa05200 | 0.62719790 |
| 100 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.61929698 |
| 101 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.60785162 |
| 102 | Viral myocarditis_Homo sapiens_hsa05416 | 0.59486901 |
| 103 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.59032032 |
| 104 | Sulfur relay system_Homo sapiens_hsa04122 | 0.58573477 |
| 105 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.55827766 |
| 106 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.54766415 |
| 107 | Axon guidance_Homo sapiens_hsa04360 | 0.54763445 |
| 108 | Insulin resistance_Homo sapiens_hsa04931 | 0.52313192 |
| 109 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.51624824 |
| 110 | Legionellosis_Homo sapiens_hsa05134 | 0.51187909 |
| 111 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.50991747 |
| 112 | Influenza A_Homo sapiens_hsa05164 | 0.50974022 |
| 113 | Hepatitis B_Homo sapiens_hsa05161 | 0.50553946 |
| 114 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.50002822 |
| 115 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.49673021 |
| 116 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.49176267 |
| 117 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.49031340 |
| 118 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.48468325 |
| 119 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.48259171 |
| 120 | Measles_Homo sapiens_hsa05162 | 0.48167793 |
| 121 | Galactose metabolism_Homo sapiens_hsa00052 | 0.47654989 |
| 122 | Amoebiasis_Homo sapiens_hsa05146 | 0.46805017 |
| 123 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.45222792 |
| 124 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.44828633 |
| 125 | Endocytosis_Homo sapiens_hsa04144 | 0.43246606 |
| 126 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.43197922 |
| 127 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.40579216 |
| 128 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.40120029 |
| 129 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.39971391 |
| 130 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.39711177 |
| 131 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.39652272 |
| 132 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.39152298 |
| 133 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.38776089 |
| 134 | Other glycan degradation_Homo sapiens_hsa00511 | 0.37228995 |
| 135 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.36364785 |
| 136 | Prion diseases_Homo sapiens_hsa05020 | 0.36119012 |
| 137 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.35605918 |
| 138 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.35089208 |
| 139 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.34708464 |
| 140 | Glioma_Homo sapiens_hsa05214 | 0.31737159 |
| 141 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.31539659 |
| 142 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.31137044 |
| 143 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.29021664 |
| 144 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.27558063 |
| 145 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.27273121 |
| 146 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.27205307 |
| 147 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.26294521 |
| 148 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.26098667 |
| 149 | Bladder cancer_Homo sapiens_hsa05219 | 0.24966404 |
| 150 | Prostate cancer_Homo sapiens_hsa05215 | 0.24963575 |
| 151 | Pertussis_Homo sapiens_hsa05133 | 0.24630492 |

